Non-steroidal anti-inflammatory drugs (NSAIDs) constitute a versatile pharmaceutical segment designed to relieve pain, reduce inflammation, and manage fever without the use of steroids. These products encompass both prescription formulations and over-the-counter (OTC) preparations such as ibuprofen and naproxen. Key advantages include targeted cyclooxygenase inhibition, rapid onset of action and fewer systemic side effects compared with corticosteroids.
As the global burden of musculoskeletal disorders, osteoarthritis and rheumatoid arthritis rises, healthcare providers and patients seek effective pain management solutions. Non-Steroidal Anti-Inflammatory Drugs Market also support postoperative recovery and can be integrated into multimodal pain relief regimens. Growing patient awareness, favorable reimbursement policies and innovations in extended-release and topical formulations are expanding the market scope. A robust market research ecosystem tracks evolving market trends and competitive landscape, enabling market players to refine growth strategies. With improved patient adherence driven by digital health tools and telemedicine, the industry size continues to expand.
The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 25.84 Bn in 2025 and is expected to reach USD 38.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Key Takeaways
Key players operating in the Non-Steroidal Anti-Inflammatory Drugs Market are Pfizer Inc., Johnson & Johnson Services, Inc., Bayer AG, Sanofi and GSK plc. These market companies maintain significant industry share through extensive portfolios that span OTC analgesics to prescription NSAIDs. Their market research capabilities drive product innovation—ranging from nanoparticle-based delivery systems to fixed-dose combinations—and strengthen market growth strategies. Strategic collaborations, licensing agreements and acquisitions further bolster their competitive edge, ensuring robust market revenue streams and reinforcing leadership across key regional segments.

Non-Steroidal Anti-Inflammatory Drugs
https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market